Electromagnetic field exposure may cause increased production of amyloid beta and eventually lead to Alzheimer's disease

Neurology

Volumn 47, Issue 6, 1996, Pages 1594-1600

  Sobel, Eugene ^a   Davanipour, Zoreh ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CALCIUM ION; CLUSTERIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD VESSEL; DEMENTIA; DISEASE PREDISPOSITION; ELECTROMAGNETIC FIELD; HUMAN; OCCUPATIONAL EXPOSURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0029769938     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.6.1594     Document Type: Article

References (51)

1. Selkoe DJ. Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease. Neurobiol Aging 1989;10:387-395.
2. Joachim CL, Mori H, Selkoe DJ. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease. Nature 1989;341:226-230.
3. Sobel E, Davanipour Z, Sulkava R, et al. Occupations with exposure to electromagnetic fields: a possible risk factor for Alzheimer's disease. Am J Epidemiol 1995;142:515-524.
4. Sobel E, Dunn M, Davanipour Z, et al. Elevated risk of Alzheimer's disease among workers with likely electromagnetic field exposure. Neurology 1996;47:1477-1481.
5. Bowman JD, Sobel E, London SJ, et al. Electric and magnetic field exposures and leukemia risk in "electrical" occupations. Final Report. Electric Power Research Institute Contract RP 799-27, 1992.
6. London SJ, Bowman JD, Sobel E, et al. Exposure to magnetic fields among electrical workers in relation to leukemia risk in Los Angeles County. Am J Indust Med 1994;26:47-60.
7. Davanipour Z, Sobel E, Hietanen M, et al. Magnetic field exposure from industrial sewing machines in Finnish apparel factories. The annual review of research on biological effects of electric and magnetic fields from the generation, delivery & use of electricity. Palm Springs, CA, November 12-16, 1995: 109.
8. Hansen NH, Gillette L, Sobel E, et al. Measurement and spectral characterization of magnetic fields in the garment industry. The annual review of research on biological effects of electric and magnetic fields from the generation, delivery & use of electricity. Palm Springs, CA, November 12-16, 1995: 38.
9. Glenner DD. Alzheimer's disease: multiple cerebral amyloidosis. In: Katzman R, ed. Banbury report 15: biological aspects of Alzheimer's disease. New York: Cold Spring Harbor Lab., 1983.
10. Selkoe DJ. Altered structural proteins in plaques and tangles: what do they tell us about the biology of Alzheimer's disease? Neurobiol Aging 1986;7:425-432.
11. Soininen H, Syrjanen S, Heinonen O, et al. Amyloid β-protein deposition in skin of patients with dementia. Lancet 1992;339: 245.
12. Seubert P, Vigo-Pelfrey C, Esch F, et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 1992;359:325-327.
13. Johnstone EM, Chaney MO, Norris FH, et al. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear, and five other mammals by cross-species polymerase chain reaction analysis. Mol Brain Res 1991;10:299-305.
14. Graff-Radford NR, Eckman C, Younkin S. Amyloid β in plasma of Alzheimer's disease patients and controls. Neurology 1996;46 (suppl):A161.
15. Haass C, Schlossmacher MG, Hung AY, et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 1992;59:322-325.
16. Shoji M, Golde TE, Ghiso J, et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 1992;258:126-129.
17. Seubert P, Oltersdorf T, Lee MG, et al. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 1993;361:260-263.
18. Querfurth HW, Selkoe DJ. Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 1994; 33:4550-4561.
19. Buxbaum JD, Ruefli AA, Parker CA, et al. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc Natl Acad Sci USA 1994;91:4489-4493.
20. Li Q-K, Berndt MC, Bush AI, et al. Membrane-associated forms of the βA4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet. Blood 1994;84:133-142.
21. Li Q-K, Evin G, Small DH, et al. Proteolytic processing of Alzheimer's disease βA4 amyloid precursor protein in human platelets. J Biol Chem 1995;270:14140-14147.
22. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
23. Wisniewski T, Golabek A, Matsubara E, et al. Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Commun 1993;192:359-365.
24. Strittmatter WJ, Weisgraber KY, Huang D, et al. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8098-8102.
25. Zlokovic BV, Ghiso J, Mackic JB, et al. Blood-brain barrier transport of circulating Alzheimer's amyloid beta. Biochem Biophys Res Commun 1993;197:1034-1040.
26. Zlokovic BV, Martel CL, Mackic JB, et al. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem Biophys Res Commun 1994;205:1431-1437.
27. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.
28. Bawin SM, Adey WR. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proc Natl Acad Sci USA 1976;73:1999-2003.
29. 2+ from chicken cerebral tissue by electromagnetic fields. Proc Natl Acad Sci USA 1978;75:6314-6318.
30. Blackman DF, Benane SG, Kinney LS, et al. Effects of ELF fields on calcium-ion efflux from brain tissue in vitro. Radiat Res 1982;92:510-520.
31. 2+ in the effect of very low frequency electromagnetic field on the blastogenesis of human lymphocytes. FEBS Lett 1985;181:28-32.
32. Colacicco G, Pilla AA. Electromagnetic modulation of biological processes: chemical, physical, and biological correlations in the Ca-uptake by embryonal chick tibia in vitro. Bioelectrochem Bioenerget 1983;10:119-131.
33. Emilia G, Torelli G, Ceccherelli G, et al. Effect of low-frequency low-energy pulsing electromagnetic fields on the response to lectin stimulation of human normal and chronic lymphocytic leukemia lymphocytes. J Bioelec 1985;4:145-161.
34. 2+ incorporation in human lymphocytes. Cell Calcium 1987;8:413-427.
35. 2+ metabolism in activated rat thymocytes [abstract #E-3-2]. Bioelectromagnetics Society, 12th Annual Meeting, June 1990, San Antonio, Tx.
36. Lyle DB, Wang X, Ayotte RD, et al. Calcium uptake by leukemic and normal T-lymphocytes exposed to low frequency magnetic fields. Bioelectromagnetics 1991;12:145-156.
37. Yost MG, Liburdy RP. Time-varying and static magnetic fields act in combination to alter calcium signal transduction in the lymphocyte. FEBS Lett 1993;296:117-122.
38. Lednev LL. Possible mechanisms for the influence of weak magnetic fields on biological systems. Bioelectromagnetics 1991;12:71-75.
39. Lindstrom E, Lindstrom P, Berglund A, et al. Intracellular calcium oscillations induced in a T-cell line by a weak 50 Hz magnetic field. J Cell Physiol 1993;156:395-398.
40. Lindstrom E, Lindstrom P, Berglund A, et al. Intracellular calcium oscillations in a T-cell line after exposure to extremely-low-frequency magnetic fields with variable frequencies and flux densities. Bioelectromagnetics 1995;16:41-47.
41. Lindstrom E, Berglund A, Hansson Mild K, et al. CD45 phosphatase in Jurkat cells is necessary for response to applied ELF magnetic fields. FEBS Lett 1995;370:118-122.
42. Walleczek J, Budinger TF. Pulsed magnetic field effects on calcium signaling in lymphocytes: dependence on cell status and field intensity. FEBS Lett 1992;314:351-355.
43. 2+ ion transport through patch-clamped cells exposed to magnetic fields. Bioelectromagnetics 1995;16:33-40.
44. Garcia-Sancho J, Montero M, Alvarez J, et al. Effects of extremely-low-frequency electromagnetic fields on ion transport in several mammalian cells. Bioelectromagnetics 1994; 15:579-588.
45. Eichwald C, Kaiser F. Model for external influences on cellular signal transduction pathways including cytosolic calcium oscillations. Bioelectromagnetics 1995;16:75-85.
46. Saunders AM, Strittmater WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
47. Corder EH, Saunders AM, Strittmatter WJ, et al. Association of apolipoprotein E allele ε4 and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923.
48. Rebeck GW, Perls TT, West HL, et al. Reduced apolipoprotein ε4 frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994;44:1513-1516. (Correction: Neurology 1995;45:598.)
49. Sobel E, Louhija J, Sulkava R, et al. Lack of association of apolipoprotein E allele ε-4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1995;45:903-907.
50. Verkasalo P, Pukkala E, Hongisto M, et al. Risk of cancer in Finnish children living close to power lines. Br Med J 1993; 307:895-899.
51. Valjus J, Hongisto M, Jarvinen P, et al. The exposure estimation method of the Finnish cohort study of cancer and exposure to magnetic fields. In: Blank M, ed. Electricity and magnetism in biology and medicine. San Francisco: San Francisco Press, 1993:426-430.